Onyx Biotec Limited

₹34.00As of Sun 8 Nov 2026, 12:00 UTC
NSE:ONYXHealthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE (0.39%)
Pharmaceutical Preparations
Beta (5Y) (0.23)
PE TTM —
TSR TTM (12.82%)
Mkt cap ₹616.5M
ROIC 0.55%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹37
7.86%
329.90%
Sell 2|2|9|2|12
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
0.71
0.68
0.65
0.63
20.30%
7.27%
(7.86%)
(9.44%)
Revenue₹M
32.04
32.70
33.85
34.17
2.91%
5.10%
5.81%
6.95%
Peers (US$6.681M)
Cap (US$)
PE
5.961M
3.176x
Capital
TTM
5Y
10Y
Leveragex
0.605
0.107
0.087
EBIT/Intx
0.229
0.190
0.179
Own earn%
5.92
66.93
71.11
Sh yield%
23.92
33.88
32.42
Owners
Insiders/Inst%
10.72
23.41
Short interest%
4.78
SBC / revenue%
5.98
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
1–7
$1 testx
0.0
Incr. ROIC%
39